Section Arrow
DTIL.NASDAQ
- Precision BioSciences
Quotes are at least 15-min delayed:2024/05/16 01:28 EDT
Last
 12.09
+0.47 (+4.04%)
Day High 
12.51 
Prev. Close
11.62 
1-M High
14.39 
Volume 
87.86K 
Bid
12.01
Ask
12.1
Day Low
11.91 
Open
11.92 
1-M Low
9.1501 
Market Cap 
80.37M 
Currency USD 
P/E -- 
%Yield
10-SMA 10.9 
20-SMA 10.5 
50-SMA 11.94 
52-W High 27.018 
52-W Low 8.25 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-15.96/-2.87
Enterprise Value
88.09M
Balance Sheet
Book Value Per Share
2.73
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
48.73M
Operating Revenue Per Share
7.56
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 01:28 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.